ArticleJHEP reports : innovation in hepatology2026

Reply to: "Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascites": Aiming at a Moving Target: ReMELD-Na Before and After Portal Decompression.

Markus Kimmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.